TY - JOUR
T1 - Prognostic value of the 6-min walk test derived attributes in patients with idiopathic pulmonary fibrosis
AU - Bloem, Ada E.M.
AU - Dolk, Hanneke M.
AU - Wind, Anne E.
AU - van der Vis, Joanne J.
AU - Kampen, Maarten J.
AU - Custers, Jan W.H.
AU - Spruit, Martijn A.
AU - Veltkamp, Marcel
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2025/1
Y1 - 2025/1
N2 - Introduction: Idiopathic pulmonary fibrosis (IPF) is a fatal progressive fibrosing lung disease. A decreased 6-min walk distance (6MWD) and exercise-induced oxygen desaturation measured during the 6-min walk test (6MWT), are known predictors of mortality in patients with IPF. However, the use of antifibrotic drugs showed a survival benefit in IPF. Therefore, this study aimed to evaluate to what extend 6MWT-derived attributes are associated with two-year survival when antifibrotic drugs were introduced as part of standard IPF-care. Methods: This real-world data-study included patients with IPF with a 6MWT between 2015 and 2020, and used composite outcome: mortality or lung transplantation within 2 years of follow-up. Data were collected systematically, including demographics, pulmonary function tests, comorbidities, medications and 6MWT-derived attributes. The prediction attributes of 6MWT were studied with a Cox Proportional-Hazards model and Kaplan-Meier survival curves. The best discriminating attribute to predict mortality was added to the prediction model Gender-Age-Physiology (GAP). Results: In 216 patients, 2-year transplant-free survival cut-off points were identified for the 6MWD (≥413 m), 6MWD %predicted (≥83 %), SpO2-nadir (≥86 %) and distance-saturation-product (≥374 m%), with the best discriminative value for SpO2-nadir (area under the curve: 0.761). 2-Year survival percentage of patients with SpO2-nadir below or above threshold (86 %) was 37.1 % and 80.0 %, respectively. Exercise-induced oxygen desaturation added to the GAP model showed an improvement in its predictive power. Conclusion: Patients with IPF who have an exercise-induced oxygen desaturation have worse prognosis. Addition of SpO2-nadir to the GAP model seems promising for use in clinical care of IPF patients.
AB - Introduction: Idiopathic pulmonary fibrosis (IPF) is a fatal progressive fibrosing lung disease. A decreased 6-min walk distance (6MWD) and exercise-induced oxygen desaturation measured during the 6-min walk test (6MWT), are known predictors of mortality in patients with IPF. However, the use of antifibrotic drugs showed a survival benefit in IPF. Therefore, this study aimed to evaluate to what extend 6MWT-derived attributes are associated with two-year survival when antifibrotic drugs were introduced as part of standard IPF-care. Methods: This real-world data-study included patients with IPF with a 6MWT between 2015 and 2020, and used composite outcome: mortality or lung transplantation within 2 years of follow-up. Data were collected systematically, including demographics, pulmonary function tests, comorbidities, medications and 6MWT-derived attributes. The prediction attributes of 6MWT were studied with a Cox Proportional-Hazards model and Kaplan-Meier survival curves. The best discriminating attribute to predict mortality was added to the prediction model Gender-Age-Physiology (GAP). Results: In 216 patients, 2-year transplant-free survival cut-off points were identified for the 6MWD (≥413 m), 6MWD %predicted (≥83 %), SpO2-nadir (≥86 %) and distance-saturation-product (≥374 m%), with the best discriminative value for SpO2-nadir (area under the curve: 0.761). 2-Year survival percentage of patients with SpO2-nadir below or above threshold (86 %) was 37.1 % and 80.0 %, respectively. Exercise-induced oxygen desaturation added to the GAP model showed an improvement in its predictive power. Conclusion: Patients with IPF who have an exercise-induced oxygen desaturation have worse prognosis. Addition of SpO2-nadir to the GAP model seems promising for use in clinical care of IPF patients.
KW - 6-min walk test (6MWT)
KW - Functional exercise capacity
KW - GAP (Gender-Age-Physiology) model
KW - Idiopathic pulmonary fibrosis (IPF)
KW - Physiotherapy
KW - Prognostic
UR - http://www.scopus.com/inward/record.url?scp=85210060417&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2024.107862
DO - 10.1016/j.rmed.2024.107862
M3 - Article
AN - SCOPUS:85210060417
SN - 0954-6111
VL - 236
JO - Respiratory Medicine
JF - Respiratory Medicine
M1 - 107862
ER -